Zocdoc for Dentists: What a $110 Booking Really Costs Your Dental Practice
In 2007, Zocdoc launched with an idea that now seems almost ordinary. A patient should be able to find a doctor who accepts their insurance, see available appointments and book online without calling multiple offices. At first, almost nobody cared. Zocdoc reportedly generated only five bookings during its first month, three from competitors checking out the service. But patients eventually embraced online healthcare shopping, particularly in large cities, and Zocdoc grew into one of healthcare technology’s best known startups. By 2015 it had raised roughly $130 million and received a private market valuation of $1.8 billion. Behind that valuation, however, CEO Dr. Oliver Kharraz says the economics were failing.
Zocdoc originally charged providers a flat subscription, roughly $3,000 to $3,600 per year, regardless of how many patients the platform generated. That created an obvious mismatch. A physician receiving a handful of patients could pay essentially the same amount as a Manhattan doctor receiving hundreds. Low volume providers had little reason to join, while Zocdoc’s busiest customers were receiving enormous value for a modest fixed price. Kharraz says the company eventually reached the point where each additional sale was losing money. The valuation looked impressive, but Zocdoc says the underlying business model was threatening the company’s survival.
The solution would save Zocdoc and anger many of its customers. Instead of charging primarily for access to the platform, Zocdoc moved toward charging providers when new patients booked appointments. The company argued that providers receiving little business should pay little, while those receiving large numbers of patients should pay more. In New York, where Zocdoc had become deeply embedded in healthcare shopping, some physicians suddenly faced bills many times larger than their old subscriptions. Doctors protested, lawsuits followed and one petition opposing the change attracted more than 1,200 signatures. Zocdoc slowed portions of the rollout, listened to providers and continued anyway. The company ultimately reported its first full year of profitability in 2023.
Dentists on Dentaltown were watching the economics unfold in real time. One Manhattan dentist reported paying about $3,000 a year under the old model, then roughly $10,000 a month after moving to about $110 per booking. That is approximately $120,000 a year, close to a 40 fold increase. The practice reported about 90 new patients a month from Zocdoc, with roughly 20 to 30 percent becoming no shows, same day cancellations or reschedules. Another New York dentist reported realizing only about 40 to 50 percent of Zocdoc bookings as actual patients. Other dentists defended the service, saying they routinely paid $200 to $350 to acquire a patient through other marketing channels and would gladly pay $110 if Zocdoc reliably put someone in the chair.
That disagreement is more useful than asking whether Zocdoc is good or bad. The $110 number by itself tells a dentist almost nothing.
Suppose a practice pays $110 for each of 100 bookings. The bill is $11,000. If 80 patients arrive, the acquisition cost is about $138 per arrived patient. If only 60 arrive, it rises to about $183. At 40 arrivals, it becomes $275. Even those numbers are incomplete because an arrival is not necessarily a profitable patient. A PPO patient who receives an exam, radiographs and prophylaxis, generates little contribution margin and never returns may be worth less than the acquisition cost. Another patient acquired for exactly the same $110 may stay for years, refer family members and accept substantial restorative treatment.
This is where dental marketing discussions often go wrong. Dentists talk about new patient count as though every new patient were economically equivalent. A booking is different from an arrival. An arrival is different from a patient who accepts treatment. A patient who accepts treatment is different from one who remains with the practice. The number that matters is the contribution margin produced by genuinely incremental patients after subtracting the cost required to acquire them.
Zocdoc’s current terminology makes its philosophy clear. The company distinguishes paid “discovery bookings” from free “reputation bookings.” A discovery booking occurs when Zocdoc believes its marketplace helped a patient discover a provider. A reputation booking involves a patient Zocdoc believes was already seeking that provider or practice, such as an existing patient or someone booking through certain links associated with the practice. Zocdoc is therefore attempting to charge for creating demand rather than merely processing an appointment.
The difficult part is attribution. Imagine a patient finds your office through an insurance directory, searches your name, reads your reviews and eventually books through a marketplace. Who created that patient relationship? Your reputation did some of the work. Your insurance participation did some. Google may have helped. Zocdoc may have helped. The marketing channel claiming credit naturally wants the answer to be Zocdoc. The dental practice should be more skeptical because attribution determines what it pays.
The no show policy causes even more friction. Zocdoc states that providers should generally expect to pay for discovery bookings regardless of the outcome. The charge occurs when the connection and booking are made, not when the patient enters the office. If the patient later disappears, the practice can still owe the fee. From Zocdoc’s perspective, it delivered what it sold, a patient discovery and booking opportunity. From the dentist’s perspective, paying for somebody who never sat in the chair feels very different from buying an advertisement.
Dentists also questioned whether paying a healthcare marketplace for each new patient crossed the line into illegal fee splitting or kickbacks. New York regulators gave Zocdoc favorable guidance regarding the state laws at issue. At the federal level, the HHS Office of Inspector General concluded in Advisory Opinion 19-04 that the arrangement implicated the Anti-Kickback Statute and did not fit neatly within the traditional referral service safe harbor, but OIG nevertheless considered the arrangement sufficiently low risk under the specific safeguards described that it would not impose administrative sanctions. OIG revisited the structure in Advisory Opinion 23-04 and again reached a favorable low risk conclusion under the circumstances presented. A later federal lawsuit challenging Zocdoc was dismissed, and the Second Circuit affirmed that dismissal in 2025.
That does not mean every company can charge dentists per patient and point to Zocdoc as permission. OIG advisory opinions protect the requester and the particular arrangement described. But the regulatory history makes it difficult to characterize Zocdoc’s current model as obviously illegal.
The more interesting question for dentists is economic. One Dentaltown dentist described Zocdoc as “essential” in New York City. That sentence deserves more attention than the complaint about a 4,000 percent price increase. Whenever another company becomes essential to reaching your patients, that company eventually gains pricing power. Amazon learned this with merchants, Booking.com with hotels and DoorDash with restaurants. Healthcare marketplaces operate under similar economics. Patients gather in one place because doctors are there. Doctors feel compelled to remain because patients are there. The network strengthens, and the marketplace gains leverage.
That does not make the marketplace evil. It makes dependence expensive. A dental office should distinguish owned demand from rented demand. Your patient relationships, referrals, brand, Google Business Profile, reviews, website and local reputation are assets that continue producing value. Patients acquired through someone else’s marketplace remain subject to that marketplace’s rules, algorithms and prices. Zocdoc can still be an excellent source of new patients, particularly for a new practice, an office with empty chair time or a dentist competing in a market where consumers already use the platform heavily.
Capacity also changes the answer. A dentist with unused hygiene time may rationally accept a lower margin Zocdoc patient because an empty chair produces nothing. A practice booked six weeks out may reach the opposite conclusion because a marketplace patient could displace an existing patient, referral or higher value case. The same $150 acquisition cost can therefore be excellent for one practice and destructive for another.
The proper way to evaluate Zocdoc is to treat it like any other variable cost acquisition channel. Tag every patient it generates. Track bookings, arrivals, cancellations, no shows, insurance plans, treatment acceptance, collections and retention. Measure the cohort after 30 days, 90 days and one year. Separate people Zocdoc genuinely introduced from those who probably would have reached the practice anyway. Then compare the contribution margin created by that cohort with the total money spent acquiring it.
The first calculation is total Zocdoc cost divided by incremental patients who actually arrive. The better calculation is incremental contribution margin from those patients divided by total Zocdoc cost. If every dollar spent produces several dollars of real contribution margin, keep buying patients until the marginal return deteriorates. If the economics become mediocre, lower the spending cap. If the cohort loses money, stop.
Kharraz’s larger business lesson applies just as well to dentistry. Zocdoc had a $1.8 billion valuation while, according to its CEO, the underlying economics were deteriorating. The company eventually had to stop admiring its growth and examine its unit economics. Dental practices face the same temptation when looking at a packed schedule or a large new patient count. Activity can look like success long before the numbers prove it. Would you rather own the patient relationship, or rent it?
Join the Conversation!